Advancements in CAR-T Cell Therapy for Ovarian Cancer: Current Strategies and Future Directions.

Chimeric Antigen Receptor (CAR) T-cell therapy has emerged as a transformative approach in oncology, particularly for hematologic malignancies. However, its application to solid tumors, such as ovarian cancer, remains challenging. This review discuss…

Preview only. Read the full abstract at the source